Parathyroid carcinoma is a rare endocrine malignancy with an estimated incidence of less than 1 per million population. Excessive secretion of parathyroid hormone, extremely high serum calcium level, and the deleterious effects of hypercalcaemia are the clinical manifestations of the disease. Up to 60% of patients develop multiple disease recurrences and although long-term survival is possible with palliative surgery, permanent remission is rarely achieved. Molecular drivers of sporadic parathyroid carcinoma have remained largely unknown. Previous studies, mostly based on familial cases of the disease, suggested potential roles for the tumour suppressor MEN1 and proto-oncogene RET in benign parathyroid tumourigenesis, while the tumour suppr...
BackgroundParathyroid carcinoma (PC) is a rare endocrine malignancy that can cause life-threatening ...
Most patients with refractory secondary/tertiary hyperparathyroidism have monoclonal parathyroid tum...
Loss of heterozygosity (LOH) analysis and comparative genomic hybridization (CGH) were used in an at...
Parathyroid carcinoma (PC) is an extremely rare malignancy lacking effective therapeutic interventio...
Parathyroid carcinoma (PC) may occur as part of a complex hereditary syndrome or an isolated (i.e. n...
Parathyroid carcinoma (PC) is a rare neoplasia difficult to diagnose preoperatively. It mainly occur...
Primary hyperparathyroidism commonly results from a benign adenoma of the parathyroid gland and rare...
Parathyroid carcinoma (PC) is a rare endocrine malignancy, accounting for <1% of all cases of sporad...
Parathyroid disease and tumor formation can occur both as a primary process and as a complication of...
Primary hyperparathyroidism (pHPT) is a common endocrine disease that in more than 95% of cases is s...
Parathyroid tumors are rare endocrine neoplasms affecting 0.1–0.3% of the general population, includ...
Context: Cell division cycle 73 (CDC73), encoding the protein parafibromin, is the most prevalent mu...
Nineteen cases of parathyroid carcinoma in patients with multiple endocrine neoplasia type 1 have be...
Primary hyperparathyroidism (PHPT), due to parathyroid tumours, may occur as part of a complex syndr...
The molecular pathogenesis of parathyroid adenomas has yet to be fully elucidated with only two gene...
BackgroundParathyroid carcinoma (PC) is a rare endocrine malignancy that can cause life-threatening ...
Most patients with refractory secondary/tertiary hyperparathyroidism have monoclonal parathyroid tum...
Loss of heterozygosity (LOH) analysis and comparative genomic hybridization (CGH) were used in an at...
Parathyroid carcinoma (PC) is an extremely rare malignancy lacking effective therapeutic interventio...
Parathyroid carcinoma (PC) may occur as part of a complex hereditary syndrome or an isolated (i.e. n...
Parathyroid carcinoma (PC) is a rare neoplasia difficult to diagnose preoperatively. It mainly occur...
Primary hyperparathyroidism commonly results from a benign adenoma of the parathyroid gland and rare...
Parathyroid carcinoma (PC) is a rare endocrine malignancy, accounting for <1% of all cases of sporad...
Parathyroid disease and tumor formation can occur both as a primary process and as a complication of...
Primary hyperparathyroidism (pHPT) is a common endocrine disease that in more than 95% of cases is s...
Parathyroid tumors are rare endocrine neoplasms affecting 0.1–0.3% of the general population, includ...
Context: Cell division cycle 73 (CDC73), encoding the protein parafibromin, is the most prevalent mu...
Nineteen cases of parathyroid carcinoma in patients with multiple endocrine neoplasia type 1 have be...
Primary hyperparathyroidism (PHPT), due to parathyroid tumours, may occur as part of a complex syndr...
The molecular pathogenesis of parathyroid adenomas has yet to be fully elucidated with only two gene...
BackgroundParathyroid carcinoma (PC) is a rare endocrine malignancy that can cause life-threatening ...
Most patients with refractory secondary/tertiary hyperparathyroidism have monoclonal parathyroid tum...
Loss of heterozygosity (LOH) analysis and comparative genomic hybridization (CGH) were used in an at...